Skip to main content
. Author manuscript; available in PMC: 2009 Sep 14.
Published in final edited form as: Fukushima J Med Sci. 2008 Dec;54(2):61–72. doi: 10.5387/fms.54.61

Table 1.

Association of SCGB3A2 With Clinicopathological Variables

Variables Negative (%) Positive (%)
Total P value
(−) (+) (2+) total (+, 2+)
Age < Median 27 (28.7) 39 (41.5) 28 (29.8) 67 (71.3) 94 0.340
≤ Median 13 (21.0) 24 (38.7) 25 (40.3) 49 (79.0) 62
Sex Male 31 (31.0) 39 (39.0) 30 (30.0) 69 (69.0) 100 0.100
Female 9 (16.1) 24 (42.9) 23 (41.1) 47 (83.9) 56
Histology* Ad 13 (13.5) 40 (41.7) 43 (44.8) 83 (86.5) 96 <0.001
Sq 22 (50.0) 18 (40.9) 4 (9.1) 22 (50.0) 44
LC 1 (11.1) 3 (33.3) 5 (55.6) 8 (88.9) 9
SCLC 4 (57.1) 2 (28.6) 1 (14.3) 3 (42.9) 7
Differentiation Well 7 (12.5) 21 (37.5) 28 (50.0) 49 (87.5) 56 0.720
Moderately 5 (14.7) 17 (50.0) 12 (35.3) 29 (85.3) 34
Poor 1 (16.7) 2 (33.3) 3 (50.0) 5 (83.3) 6
Subtype Pap 6 (9.1) 26 (39.4) 34 (51.5) 60 (90.9) 66 0.040
Tub 5 (38.5) 4 (30.8) 4 (30.8) 8 (61.5) 13
BAC 2 (12.5) 9 (56.3) 5 (31.3) 14 (87.5) 16
Morphology§ Clara + typeII 4 (9.5) 17 (40.5) 21 (50.0) 38 (90.5) 42 0.006
Ciliated 2 (5.3) 17 (44.7) 19 (50.0) 36 (94.7) 38
Goblet 3 (60.0) 1 (20.0) 1 (20.0) 2 (40.0) 5
Bronchial gland 4 (36.4) 5 (45.5) 2 (18.2) 7 (63.6) 11
Stage I, II 18 (20.7) 40 (46.0) 29 (33.3) 69 (79.3) 87 0.178
III, IV 22 (33.3) 23 (34.8) 21 (31.8) 44 (66.7) 66
Total 40 (25.6) 63 (40.4) 53 (34.0) 116 (74.4) 156
*

Ad, adenocarcinoma; Sq, squamous cell carcinoma; LC, large cell carcinoma; SCLC, small cell carcinoma.

Only adenocarcinomas were included.

Only adenocarcinomas were included. Pap, papillary adenocarcinoma; Tub, tubular adenocarcinoma; BAC, bronchiolo-alveolar carcinoma

Only adenocarcinomas were included.

§

Clara + type II, Clara cell/ type II alveolar epithelial cell type; Ciliated, ciliated epithelial cell type; Goblet, goblet cell type; Bronchial gland, bronchial gland cell type.